146 related articles for article (PubMed ID: 15228164)
1. Genetics of the variable expression of CYP3A in humans.
Wojnowski L
Ther Drug Monit; 2004 Apr; 26(2):192-9. PubMed ID: 15228164
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 3A and their regulation.
Burk O; Wojnowski L
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):105-24. PubMed ID: 14569421
[TBL] [Abstract][Full Text] [Related]
3. Genetic contribution to variable human CYP3A-mediated metabolism.
Lamba JK; Lin YS; Schuetz EG; Thummel KE
Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
[TBL] [Abstract][Full Text] [Related]
4. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene.
Gellner K; Eiselt R; Hustert E; Arnold H; Koch I; Haberl M; Deglmann CJ; Burk O; Buntefuss D; Escher S; Bishop C; Koebe HG; Brinkmann U; Klenk HP; Kleine K; Meyer UA; Wojnowski L
Pharmacogenetics; 2001 Mar; 11(2):111-21. PubMed ID: 11266076
[TBL] [Abstract][Full Text] [Related]
5. Intestinal expression and metabolic activity of the CYP3A subfamily in female rats.
Aiba T; Yoshinaga M; Ishida K; Takehara Y; Hashimoto Y
Biol Pharm Bull; 2005 Feb; 28(2):311-5. PubMed ID: 15684490
[TBL] [Abstract][Full Text] [Related]
6. Induction of CYP3A by ethanol in multiple in vitro and in vivo models.
Feierman DE; Melinkov Z; Nanji AA
Alcohol Clin Exp Res; 2003 Jun; 27(6):981-8. PubMed ID: 12824820
[TBL] [Abstract][Full Text] [Related]
7. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells.
Ohmori S; Nakasa H; Asanome K; Kurose Y; Ishii I; Hosokawa M; Kitada M
Biochim Biophys Acta; 1998 May; 1380(3):297-304. PubMed ID: 9555064
[TBL] [Abstract][Full Text] [Related]
8. Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.
Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Saito T; Parkinson A; Nakagawa K; Kamataki T
Xenobiotica; 2005 Jan; 35(1):69-83. PubMed ID: 15788369
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
Pinto AG; Wang YH; Chalasani N; Skaar T; Kolwankar D; Gorski JC; Liangpunsakul S; Hamman MA; Arefayene M; Hall SD
Clin Pharmacol Ther; 2005 Mar; 77(3):178-88. PubMed ID: 15735612
[TBL] [Abstract][Full Text] [Related]
10. Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man.
Gibson GG; Plant NJ; Swales KE; Ayrton A; El-Sankary W
Xenobiotica; 2002 Mar; 32(3):165-206. PubMed ID: 11958559
[TBL] [Abstract][Full Text] [Related]
11. Genotype relationships in the CYP3A locus in Caucasians.
Dally H; Bartsch H; Jäger B; Edler L; Schmezer P; Spiegelhalder B; Dienemann H; Drings P; Kayser K; Schulz V; Risch A
Cancer Lett; 2004 Apr; 207(1):95-9. PubMed ID: 15050738
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.
Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M
Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982
[TBL] [Abstract][Full Text] [Related]
13. Genetics. SNP-ing drugs to size.
Gura T
Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082
[No Abstract] [Full Text] [Related]
14. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors.
Pascussi JM; Gerbal-Chaloin S; Drocourt L; Maurel P; Vilarem MJ
Biochim Biophys Acta; 2003 Feb; 1619(3):243-53. PubMed ID: 12573484
[TBL] [Abstract][Full Text] [Related]
15. Impact of transcription factor profile and chromatin conformation on human hepatocyte CYP3A gene expression.
Phillips A; Hood SR; Gibson GG; Plant NJ
Drug Metab Dispos; 2005 Feb; 33(2):233-42. PubMed ID: 15523048
[TBL] [Abstract][Full Text] [Related]
16. Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.
Rodríguez-Antona C; Jande M; Rane A; Ingelman-Sundberg M
Clin Pharmacol Ther; 2005 Apr; 77(4):259-70. PubMed ID: 15903124
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of alfentanil by cytochrome p4503a (cyp3a) enzymes.
Klees TM; Sheffels P; Dale O; Kharasch ED
Drug Metab Dispos; 2005 Mar; 33(3):303-11. PubMed ID: 15557344
[TBL] [Abstract][Full Text] [Related]
18. CYP3A genetics in drug metabolism.
Eichelbaum M; Burk O
Nat Med; 2001 Mar; 7(3):285-7. PubMed ID: 11231620
[No Abstract] [Full Text] [Related]
19. Cyp3A regulation: from pharmacology to nuclear receptors.
Quattrochi LC; Guzelian PS
Drug Metab Dispos; 2001 May; 29(5):615-22. PubMed ID: 11302925
[TBL] [Abstract][Full Text] [Related]
20. Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.
Reid JM; Kuffel MJ; Ruben SL; Morales JJ; Rinehart KL; Squillace DP; Ames MM
Clin Cancer Res; 2002 Sep; 8(9):2952-62. PubMed ID: 12231541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
